Literature DB >> 9773391

Lumping of whole-body physiologically based pharmacokinetic models.

I A Nestorov1, L J Aarons, P A Arundel, M Rowland.   

Abstract

Lumping is a common pragmatic approach aimed at the reduction of whole-body physiologically based pharmacokinetic (PBPK) model dimensionality and complexity. Incorrect lumping is equivalent to model misspecification with all the negative consequences to the subsequent model implementation. Proper lumping should guarantee that no useful information about the kinetics of the underlying processes is lost. To enforce this guarantee, formal standard lumping procedures and techniques need to be defined and implemented. This study examines the lumping process from a system theory point of view, which provides a formal basis for the derivation of principles and standard procedures of lumping. The lumping principle in PBPK modeling is defined as follows: Only tissues with identical model specification, and occupying identical positions in the system structure should be lumped together at each lumping iteration. In order to lump together parallel tissues, they should have similar or close time constants. In order to lump together serial tissues, they should equilibrate very rapidly with one another. The lumping procedure should include the following stages: (i) tissue specification conversion (when tissues with different model specifications are to be lumped together); (ii) classification of the tissues into classes with significantly different kinetics, according to the basic principle of lumping above; (iii) calculation of the parameters of the lumped compartments; (iv) simulation of the lumped system; (v) lumping of the experimental data; and (vi) verification of the lumped model. The use of the lumping principles and procedures to be adopted is illustrated with an example of a commonly implemented whole-body physiologically based pharmacokinetic model structure to characterize the pharmacokinetics of a homologous series of barbiturates in the rat.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9773391     DOI: 10.1023/a:1023272707390

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  17 in total

1.  From piecewise to full physiologic pharmacokinetic modeling: applied to thiopental disposition in the rat.

Authors:  W F Ebling; D R Wada; D R Stanski
Journal:  J Pharmacokinet Biopharm       Date:  1994-08

2.  Pharmacokinetics from a dynamical systems point of view.

Authors:  J M van Rossum; J E de Bie; G van Lingen; H W Teeuwen
Journal:  J Pharmacokinet Biopharm       Date:  1989-06

3.  Physiological pharmacokinetics.

Authors:  K B Bischoff
Journal:  Bull Math Biol       Date:  1986       Impact factor: 1.758

4.  Absorption and excretion of drugs. XXXII. Absorption of barbituric acid derivatives from rat small intestine.

Authors:  K Kakemi; T Arita; R Hori; R Konishi
Journal:  Chem Pharm Bull (Tokyo)       Date:  1967-12       Impact factor: 1.645

5.  Physiologically based pharmacokinetics of radioiodinated human beta-endorphin in rats. An application of the capillary membrane-limited model.

Authors:  H Sato; Y Sugiyama; Y Sawada; T Iga; M Hanano
Journal:  Drug Metab Dispos       Date:  1987 Jul-Aug       Impact factor: 3.922

6.  Physiologically based pharmacokinetic model for cefazolin in rabbits and its preliminary extrapolation to man.

Authors:  A Tsuji; K Nishide; H Minami; E Nakashima; T Terasaki; T Yamana
Journal:  Drug Metab Dispos       Date:  1985 Nov-Dec       Impact factor: 3.922

Review 7.  Physiological parameters in laboratory animals and humans.

Authors:  B Davies; T Morris
Journal:  Pharm Res       Date:  1993-07       Impact factor: 4.200

8.  Physiologic modeling of cyclosporin kinetics in rat and man.

Authors:  A Bernareggi; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1991-02

9.  Physiologically based pharmacokinetic study on a cyclosporin derivative, SDZ IMM 125.

Authors:  R Kawai; M Lemaire; J L Steimer; A Bruelisauer; W Niederberger; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1994-10

10.  Physiologically based pharmacokinetics of a new penem, SUN5555, for evaluation of in vivo efficacy.

Authors:  A Tsuji; H Sato; I Tamai; H Adachi; T Nishihara; M Ishiguro; N Ohnuma; T Noguchi
Journal:  Drug Metab Dispos       Date:  1990 Mar-Apr       Impact factor: 3.922

View more
  32 in total

1.  Sensitivity analysis of pharmacokinetic and pharmacodynamic systems: I. A structural approach to sensitivity analysis of physiologically based pharmacokinetic models.

Authors:  I A Nestorov
Journal:  J Pharmacokinet Biopharm       Date:  1999-12

2.  Quantitative structure-pharmacokinetics relationships: II. A mechanistically based model to evaluate the relationship between tissue distribution parameters and compound lipophilicity.

Authors:  I Nestorov; L Aarons; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1998-10

Review 3.  Whole body pharmacokinetic models.

Authors:  Ivan Nestorov
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

4.  Lumping of physiologically-based pharmacokinetic models and a mechanistic derivation of classical compartmental models.

Authors:  Sabine Pilari; Wilhelm Huisinga
Journal:  J Pharmacokinet Pharmacodyn       Date:  2010-07-27       Impact factor: 2.745

Review 5.  Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation Approaches: A Systematic Review of Published Models, Applications, and Model Verification.

Authors:  Jennifer E Sager; Jingjing Yu; Isabelle Ragueneau-Majlessi; Nina Isoherranen
Journal:  Drug Metab Dispos       Date:  2015-08-21       Impact factor: 3.922

6.  A PBPK model describing a xenobiotic with a short PK event scale.

Authors:  Xiaofeng Wang; Brian E Davies
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-07-09       Impact factor: 2.745

7.  Reducing whole body physiologically based pharmacokinetic models using global sensitivity analysis: diazepam case study.

Authors:  Ivelina Gueorguieva; Ivan A Nestorov; Malcolm Rowland
Journal:  J Pharmacokinet Pharmacodyn       Date:  2005-12-20       Impact factor: 2.745

8.  Lumping in pharmacokinetics.

Authors:  Céline Brochot; János Tóth; Frédéric Y Bois
Journal:  J Pharmacokinet Pharmacodyn       Date:  2005-12       Impact factor: 2.745

9.  Physiologically based pharmacokinetic modelling: a sub-compartmentalized model of tissue distribution.

Authors:  Max von Kleist; Wilhelm Huisinga
Journal:  J Pharmacokinet Pharmacodyn       Date:  2007-09-25       Impact factor: 2.745

Review 10.  Modeling kinetics of subcellular disposition of chemicals.

Authors:  Stefan Balaz
Journal:  Chem Rev       Date:  2009-05       Impact factor: 60.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.